NETEASE VET RAISES $100M FOR GAMING STUDIO FUND
AI DESK■ 1 MIN READ
TUE, MAY 12, 2026■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE
Simon Zhu, a veteran from Chinese gaming giant NetEase, has secured $100 million to launch GreaterThan Group, a new investment firm backing established video-game creators. The fund's first major backing includes Casey Hudson, director of the acclaimed Mass Effect franchise.
GreaterThan Group targets experienced game developers seeking capital and creative independence. Hudson, who previously led BioWare's Mass Effect series, represents the caliber of talent Zhu's fund aims to support.
The investment strategy focuses on established creators rather than startups, positioning GreaterThan as a backing vehicle for industry veterans with proven track records. This approach differs from traditional venture capital models that prioritize early-stage studios.
Zhu's move comes amid broader consolidation in gaming, where major publishers have acquired numerous independent studios. GreaterThan's model suggests demand exists for alternatives that fund experienced developers without full acquisitions.
The $100 million fund demonstrates investor confidence in backing established gaming talent during a period of industry restructuring. Hudson's involvement signals potential for high-profile projects leveraging his experience on flagship franchises like Mass Effect and Star Wars initiatives.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
YESTERDAY— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
YESTERDAY— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
YESTERDAY— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk